# Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice.

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/exploring-cannabinoid-receptor-cb1-autophagy-and-the-obesity-phenotype-of-p/
> **Published:** 2026-04-28T22:01:46-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:05:09-04:00
> **Clinical Summary:** The endocannabinoid system (ECS) and the autophagy receptor p62 are both implicated in metabolic regulation and obesity, yet the mechanisms linking these pat...

---

CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action.
🔬 Evidence Watch  |  CED Clinic

Journal
Biochemistry and biophysics reports

Study Type
[Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/)

Population
Human participants

Why This Matters

This item covers developments relevant to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). Clinicians monitoring evidence in this area should review the source material.

Clinical Summary
The [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) (ECS) and the autophagy receptor p62 are both implicated in metabolic regulation and obesity, yet the mechanisms linking these pathways remain unclear. Here, we investigated whether p62 modulates [CB1 receptor](https://cedclinic.com/aelis-farma-financial-results-2025-outlook/) (CB1R) turnover or function and whether CB1R contributes to the metabolic phenotype of p62 knockout (KO) mice. In primary cortical neurons from wild-type mice, inhibition of autophagic flux with Bafilomycin A1 led to substantial CB1R accumulation, demonstrating that CB1R is a subject to autophagy-dependent degradation. CB1R agonist stimulation partially reduced this accumulation, suggesting receptor activation influences turnover. In vivo, p62 deficiency did not significantly alter CB1R protein abundance in the brain or hypothalamus, although hypothalamic ERK1/2 signaling downstream of CB1R was modestly attenuated. P62 KO mice displayed late-onset obesity without hyperphagia, early hypoactivity, and elevated hypothalamic 2-arachidonoylglycerol (2-AG) lev

Dr. Caplan’s Take

“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”

Clinical Perspective
🧠 Clinicians should review this item in the context of their current practice and patient population.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Exploring%20cannabinoid%20receptor%20CB1%20autophagy%20and%20the%20obesity%20phenotype%20of%20p62-deficient%20mice.%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fexploring-cannabinoid-receptor-cb1-autophagy-and-the-obesity-phenotype-of-p%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fexploring-cannabinoid-receptor-cb1-autophagy-and-the-obesity-phenotype-of-p%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Exploring%20cannabinoid%20receptor%20CB1%20autophagy%20and%20the%20obesity%20phenotype%20of%20p62-deficient%20mice.%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fexploring-cannabinoid-receptor-cb1-autophagy-and-the-obesity-phenotype-of-p%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

📰 Source: [https://pubmed.ncbi.nlm.nih.gov/42004545/](https://pubmed.ncbi.nlm.nih.gov/42004545/)

Table of Contents

- [FAQ](#FAQ)[What question did this p62 and CB1 receptor study ask?](#What_question_did_this_p62_and_CB1_receptor_study_ask)
- [How are CB1 receptors broken down inside nerve cells?](#How_are_CB1_receptors_broken_down_inside_nerve_cells)
- [Did losing p62 change CB1 receptor levels in the brain?](#Did_losing_p62_change_CB1_receptor_levels_in_the_brain)
- [What metabolic and behavioral traits did the p62-deficient mice show?](#What_metabolic_and_behavioral_traits_did_the_p62-deficient_mice_show)
- [Related](#Related)

## FAQ

### What question did this p62 and CB1 receptor study ask?

The [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) and the autophagy receptor p62 are both implicated in metabolic regulation and obesity, but how the two pathways are linked is unclear. The researchers investigated whether p62 affects [CB1 receptor](https://cedclinic.com/aelis-farma-financial-results-2025-outlook/) turnover or function, and whether the CB1 receptor contributes to the metabolic features of mice lacking p62.

### How are CB1 receptors broken down inside nerve cells?

In cortical neurons from wild-type mice, blocking autophagic flux with Bafilomycin A1 caused substantial CB1 receptor buildup, showing that CB1 receptors undergo autophagy-dependent degradation. Stimulating the receptor with a CB1 agonist partly reduced this buildup, suggesting that receptor activation influences receptor turnover.

### Did losing p62 change CB1 receptor levels in the brain?

Not significantly. In living mice, p62 deficiency did not significantly change the amount of CB1 receptor protein in the brain or hypothalamus. However, ERK1/2 signaling in the hypothalamus, which lies downstream of the CB1 receptor, was modestly reduced in the mice lacking p62.

### What metabolic and behavioral traits did the p62-deficient mice show?

Mice lacking p62 developed late-onset obesity without hyperphagia, meaning they became obese later in life without overeating. They also showed early hypoactivity, or reduced activity, and elevated 2-arachidonoylglycerol (2-AG) in the hypothalamus.

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).